Studies have demonstrated that cardiac-specific overexpression of inhibitor of apoptosis (BCL-2) significantly reduces infarction size after ischemia-reperfusion injury (I/R injury) (Chen et al., 2001). This evidence concerns the gene BCL2 and infarction.